Panel Discussion: Novel Biomarkers to Stratify Populations for Pinpoint Accuracy in Clinical Trials
Time: 11:35 am
day: Day Three Track B
Details:
- Revolutionizing stratification with novel biomarkers
- How will biomarkers for patient stratification differ as biopharma approach non-oncology territories?
- Deciphering the necessary steps to accurately validate biomarkers
- Stratifying patients based on clinical benefit and survival consistent with outcomes observed in the clinic
- Facilitating decision making from preclinical candidate nomination to clinical trial design to sequencing and combination of interventions
